Post by
Noteable on Jul 15, 2022 11:05am
The issue of the safe use of higher doses of vaccinia virus
https://www.biospace.com/article/releases/siga-announces-oncology-collaboration-with-kalivir-immunotherapeuticssiga-to-supply-tpoxx-to-support-kalivir-s-oncolytic-vaccinia-clinical-immunotherapy-program/
Comment by
m00nsh0ts on Jul 15, 2022 7:28pm
What issue? Also, do you know, was this the virus used in the car T study that didn't seem to work as a booster? tia
Comment by
Noteable on Jul 29, 2022 12:43pm
Correction: - Takeda is walking away from a 2019 bio-buck deal with Turnstone Biologics, that included a $120 million up-front payment for Turnstone's vaccinia virus cancer prospect.
Comment by
Noteable on Jul 21, 2023 11:18am
https://investors.genelux.com/news-releases/news-release-details/genelux-corporation-strengthens-senior-management-and-clinical The OV company Genelux's primary product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a modified strain of the vaccinia virus (VACV)